In addition, several nicely proven adverse prognostic markers, together with U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, lost their unfavorable result in sufferers treated with VO. The only issue that remained predictive of a shorter development-free survival With this cohort of sufferers was TP53 aberrations.112 Finally, the alternative BTK